Subiect Hub
Peptide pentru femei
Echilibrul hormonal, sănătatea pielii, managementul greutății și susținerea menopauzei - peptide cercetate special pentru problemele de sănătate ale femeilor.
Peptide cheie
Semaglutide
Semaglutide dosing, mechanism of action, side effects, and weight loss efficacy. Includes Ozempic an…
MonografieGHK-Cu
GHK-Cu copper peptide benefits, dosing, mechanism of action, and wound healing properties. Anti-agin…
MonografieBPC-157
BPC-157 dosing protocol, mechanism of action, side effects, and clinical evidence. Complete referenc…
MonografieThymosin Alpha-1
Thymosin alpha-1 dosing, immune modulation mechanism, side effects, and clinical evidence. Complete …
MonografieKisspeptin
Kisspeptin dosing, reproductive hormone mechanism, side effects, and fertility applications. GnRH re…
Ultimele articole
GLP-1 Receptor Agonists: A Comprehensive Comparison for Prescribers
Trying to figure out which GLP-1 medication is right for you? Here's a plain-English breakdown of th…
ClinicalGLP-1 and Exercise: How to Maximize Weight Loss with Physical Activity
Taking a GLP-1 medication? Here's why exercise isn't optional — and how to protect your muscles whil…
ClinicalSemaglutide vs Tirzepatide: Which GLP-1 Is Better for Weight Loss?
The two heavyweight champs of weight loss medications go head to head. Here's what the research actu…
ReviewHow Much Do GLP-1 Medications Actually Cost? A Realistic Breakdown
The sticker shock is real. Here's what you'll actually pay for semaglutide, tirzepatide, and other w…
GuideWhat Are GLP-1 Medications? Everything You Need to Know
If you've heard about Ozempic, Wegovy, or Mounjaro and wondered what the fuss is about — here's the …
Cercetare
Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach
This Novo Nordisk study used model-informed drug development to evaluate whether semaglutide 1.7 mg …
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis evaluated the association between GLP-1 receptor agonist use and de…
Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide
This real-world study of 293 patients found that tirzepatide produced 10.3% total body weight loss i…
Glucagon-like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis examined the relationship between GLP-1 receptor agonist use and de…
Semaglutide Efficacy Varies Across Ancestries and Is Modulated by Genetic Variation in PTPRU
Analysis of 93,936 participants from the UCLA ATLAS Community Health Initiative revealed that semagl…
Tirzepatide/Semaglutide Weight Loss Intervention in Patients With Endometrial Cancer and Obesity
Memorial Sloan Kettering is conducting a pilot study evaluating tirzepatide (with semaglutide as alt…
Ghiduri și comparații
Semaglutide vs Tirzepatide: Which GLP-1 Is Better for Weight Loss?
The two heavyweight champs of weight loss medications go head to head. Here's what the research actu…
GuideWhat Are GLP-1 Medications? Everything You Need to Know
If you've heard about Ozempic, Wegovy, or Mounjaro and wondered what the fuss is about — here's the …
Soluții conexe
Peptide pentru pierderea în greutate
Agoniștii receptorilor GLP-1 precum semaglutida și tirzepatida au transformat managementul greutății. Explorați cercetările, comparați opțiunile și înțelegeți la ce să vă așteptați.
Peptide pentru piele și păr
Peptide de cupru, stimulatori de colagen și factori de creștere pentru aplicații dermatologice. Dovezi clinice pentru repararea pielii, regenerarea părului și vindecarea rănilor.
Peptide pentru anti-îmbătrânire și longevitate
De la repararea celulară la întinerirea pielii, peptidele sunt la frontiera cercetării longevității. Explorați compușii cu cele mai solide dovezi.
Peptide pentru sănătatea intestinului
BPC-157 și alte peptide cercetate pentru vindecarea intestinului, IBS, intestin permeabil și inflamație GI. Cel mai dovedit domeniu al terapiei peptidice.